Air-Fluidized Beds Market Global Report 2026

The air-fluidized beds market size has grown strongly in recent years. It will grow from $1.15 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to rising prevalence of pressure ulcers in immobile patients, increasing hospital admissions and long-term care requirements, growing awareness of advanced wound care therapies, expansion of critical care and intensive care infrastructure, increasing adoption of specialty hospital beds in developed healthcare systems.

The air-fluidized beds market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing integration of smart sensor based therapeutic bed systems, rising demand for advanced wound healing and infection prevention solutions, growth in aging population requiring long term care support, expansion of home healthcare and remote patient monitoring, increasing healthcare investment in critical care infrastructure modernization. Major trends in the forecast period include AI-assisted patient pressure injury monitoring systems, increasing adoption of smart therapeutic support surface beds, growth in hospital intensive care pressure redistribution solutions, rising demand for moisture and temperature controlled wound care systems, integration of sensor-based adaptive airflow medical beds.

The increasing prevalence of chronic wounds is expected to propel the growth of the air-fluidized beds market going forward. Chronic wounds refer to persistent skin or tissue injuries that fail to heal through the normal recovery process within several weeks due to underlying medical conditions or impaired blood circulation. Chronic wounds are increasing primarily due to the growing prevalence of diabetes, which affects blood flow and nerve function, thereby delaying the body's natural healing process. Air-fluidized beds support patients with chronic wounds by using fine beads suspended by warm air to evenly distribute body weight, reduce pressure on wounds, improve blood circulation, and maintain an optimal moisture and temperature environment that promotes faster healing. For instance, in July 2025, according to National Seniors Australia, an Australia-based nonprofit organization, more than 450,000 Australians are affected by chronic wounds, placing an annual burden of more than $6 billion on the healthcare system. Therefore, the increasing prevalence of chronic wounds is driving the growth of the air-fluidized beds market.

The increasing healthcare expenditure is expected to propel the growth of the air-fluidized beds market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare services, goods, and systems by individuals, governments, and organizations within a given period. Healthcare expenditure is increasing primarily due to the aging population, which results in higher demand for frequent, long-term, and complex medical care. Higher healthcare expenditure supports air-fluidized beds by enabling hospitals and care facilities to invest in advanced, high-cost wound care equipment that enhances treatment outcomes for severe pressure injuries. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based health information institute, total health spending in Canada reached $344 billion in 2023, equating to $8,740 per person. This represented a 2.8% increase compared to the previous year, which recorded only a 1.5% growth in health spending in 2022, reflecting a notable rebound in healthcare investment. Therefore, the increasing healthcare expenditure is driving the growth of the air-fluidized beds market.

The increasing number of hospital-acquired infections is expected to propel the growth of the air-fluidized beds market going forward. Hospital-acquired infections (HAIs) refer to infections that patients develop during treatment in a hospital or healthcare facility that were not present at the time of admission. Hospital-acquired infections are increasing primarily due to the rising use of invasive medical devices such as catheters and ventilators, which can allow pathogens to enter the body and cause infections. Air-fluidized beds help reduce hospital-acquired infections by minimizing pressure on the skin while promoting a cleaner, drier, and low-contact surface environment that limits bacterial growth and reduces the risk of cross-contamination. For instance, in September 2024, according to the UK Health Security Agency, a UK-based government agency, during the fiscal year 2022-2023, the total number of hospital-onset healthcare-associated (HOHA) E. coli infections increased from 6,525 to 7,881 cases. Therefore, the increasing number of hospital-acquired infections is driving the growth of the air-fluidized beds market.

Major companies operating in the air-fluidized beds market are Envella Air Fluidized Therapy Bed (Baxter / Hillrom); PEARLS Full-Body Air-Fluidized Therapy System (Arjo); Ethos Therapy Solutions Inc.; AIRUS A210 Air Fluidized Therapy Unit (Blue Chip Medical Products); HydroAire Generation II Air Fluidized Therapy Bed (Aurora Manufacturing)

North America was the largest region in the air-fluidized beds market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the air-fluidized beds market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the air-fluidized beds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The air-fluidized bed market consists of sales of pulsating air-fluidized beds, continuous flow air-fluidized beds, and modular air-fluidized bed systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The air-fluidized beds market research report is one of a series of new reports that provides air-fluidized beds market statistics, including air-fluidized beds industry global market size, regional shares, competitors with a air-fluidized beds market share, detailed air-fluidized beds market segments, market trends and opportunities, and any further data you may need to thrive in the air-fluidized beds industry. This air-fluidized beds market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.